🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsCost projections for oral non-peptide GLP-1 agonists — anyone have experience? Page 4

Cost projections for oral non-peptide GLP-1 agonists — anyone have experience?

Dr.CardioMD Tue, Feb 24, 2026 at 10:03 AM 23 replies 1,028 viewsPage 4 of 5
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Mar 5, 2026 at 2:44 AM#16

Adding the clinical framing, because it changes how the question reads. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

21 21paul_denver, TinaHashiRN, robert_kc and 18 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Mar 6, 2026 at 4:50 AM#17

Clinical perspective, offered as context rather than as advice. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

Worth separating that from cost and coverage, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

20 20PharmD_Rodriguez, julia.endo, JessicaM_2024 and 17 others
Reply Quote Save Share Report
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Mar 7, 2026 at 6:57 AM#18
LibrarianMeg said:
Start from the measurement rather than the conclusion.

This matches mine closely enough to be worth saying so out loud. I had assumed I was the exception until I read this.

19 19TomTeleRx, DoseLogDan, SleepFixSam and 16 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Mar 8, 2026 at 9:04 AM#19
LibrarianMeg said:
Start from the measurement rather than the conclusion.

There is a second half to this that has not been said yet. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Worth separating that from cost and coverage, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Mar 8, 2026 at 1:04 PM
18 18JessicaM_2024, TomFromTexas, mike.trainer_LA and 15 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Mar 9, 2026 at 11:12 AM#20

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Tagging this one for the weekly digest.

46 21PurityPaulOR, MaxMetOK, MounjBrad and 43 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register